guest ::
| Home > Authorities > Grants > Record #7323 |
REGENER-AR
Bringing Regenerative Medicine into the market: Allogeneic eASCs Phase IB/IIA clinical trial for treating Rheumatoid Arthritis
| Coordinator | CENTRO DE INVESTIGACIONES ENERGETICAS, MEDIOAMBIENTALES Y TECNOLOGICAS-CIEMAT ; THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD ; Mondragon Assembly (Spain) ; SISTEMIC SCOTLAND LIMITED ; TIGENIX SA ; FARMA-CROS IBERICA S.L. ; TiGENIX NV ; Inserm ; Zabala Innovation Consulting (Spain) ; ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM |
| Grant period | 2012-01-01 - 2014-12-31 |
| Funding body | European Union |
| Call number | FP7-HEALTH-2011-two-stage |
| Grant number | 279174 |
| Identifier | G:(EU-Grant)279174 |
